CSIMarket Company Name, Ticker, Industry, else..
• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Inc. COP Y/Y Annual
Evolutionary Genomics Inc   (FNAM)
Other Ticker:  
 
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare
 

Evolutionary Genomics Inc 's Yearly Income from Continued Operations Growth 5 Years
 

Select the Comparisons : Select the Ratio:



FNAM Annual Income from Cont. Operations Growth

 2021
2020
2019
2018
2017
Y / Y Annual Income from Cont. Operations Change - - - - -
Annual Income from Cont. Operations (in millions $) $-2.79 $-1.71 $-0.79 $-1.10 $-0.54

FNAM Company Profile >> Back to FNAM Fundamentals at a Glance >> Back to FNAM Growth Comparisons

Annual Income from Cont. Operations Growth Comment
Evolutionary Genomics Inc realized loss from Cont. Operations.

Evolutionary Genomics Inc Annual Income Statement




You need to upgrade your Flash Player



Companies with similar 2021 Annual Income from Cont. Operations within Healthcare SectorY/Y Income from Continued Operations Growth %2021 Annual Income from Cont. Operations
Denali Therapeutics Inc -99.60 %$ 0.575  millions
Msa Safety Inc -82.02 %$ 21.788  millions
Alpha Pro Tech Ltd -74.29 %$ 15.256  millions
Pharming Group N v -56.77 %$ 15.996  millions
Viemed Healthcare Inc -71.06 %$ 9.126  millions
Purple Biotech Ltd -34.22 %$ 18.468  millions
Lemaitre Vascular Inc  26.80 %$ 26.907  millions
Beyond Air Inc.